Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease
about
sameAs
C-reactive protein (CRP)-lowering agentsA review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.Association of in vivo β-adrenergic receptor sensitivity with inflammatory markers in healthy subjects.Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study.The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in manCurrent pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics.Beta-blockers and risk of all-cause mortality in non-cardiac surgery.Peri-operative cardiac protection for non-cardiac surgery.Beta-Blockers and Calcium Channel Blockers: First Line Agents.Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism.Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.Seasonal variation of C-reactive protein and atherosclerotic cardiovascular events in hemodialysis patients.The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
P2860
Q28200344-1149D4B6-3B60-46CA-8D46-C449801B2C30Q34567560-0663628A-BACB-4164-9D23-0E23ACD51760Q35123336-56761991-9F38-4C13-9FE2-3875F1F1A909Q36003486-E67C96DA-B20B-46AE-A160-939EE457D56FQ37252436-318D2DBB-541A-4900-A55A-CA9E03CB6C9CQ37479070-94D43FFC-BDD7-4474-B378-6635628DC9E8Q37645663-2EA47A17-8A1F-4586-8D05-FFB781B22ECEQ37702033-8415B5F4-A7D8-4C3D-9231-83DB5E35BF0BQ38653570-3D355F7D-5A7A-4800-B0C5-892AD72E609DQ38941375-7221D47A-1998-432C-A894-547FA47ACBC9Q41787966-DCE40BCC-81C5-471D-A872-F2ACF8B3605AQ42829752-D2E5CF7E-C3F0-4199-9251-957161DF22C6Q44439514-F9E23B2E-91F5-4DE5-95A0-7B0F6F5B2744Q44479268-3AE6AAB3-76B0-4AF2-B510-D799817D283B
P2860
Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Beta-blockers are associated w ...... s with coronary artery disease
@ast
Beta-blockers are associated w ...... s with coronary artery disease
@en
Beta-blockers are associated w ...... s with coronary artery disease
@nl
type
label
Beta-blockers are associated w ...... s with coronary artery disease
@ast
Beta-blockers are associated w ...... s with coronary artery disease
@en
Beta-blockers are associated w ...... s with coronary artery disease
@nl
prefLabel
Beta-blockers are associated w ...... s with coronary artery disease
@ast
Beta-blockers are associated w ...... s with coronary artery disease
@en
Beta-blockers are associated w ...... s with coronary artery disease
@nl
P2093
P1476
Beta-blockers are associated w ...... s with coronary artery disease
@en
P2093
Brian G Keevil
Ian V Hutchinson
Nicholas H Brooks
Nicholas P Jenkins
P304
P356
10.1016/S0002-9343(01)01115-9
P407
P577
2002-03-01T00:00:00Z